Tilray’s Earnings Call: Growth Amid Challenges

Tilray ((TLRY)) has held its Q1 earnings call. Read on for the main highlights of the call.

The recent earnings call for Tilray showcased a balanced sentiment, highlighting significant achievements in revenue growth and international expansion, while also addressing challenges in the Beverage segment and permitting delays in Portugal. The company demonstrated resilience and strategic foresight amidst these mixed outcomes.

Record Net Revenue

Tilray achieved a record net revenue of $210 million for the first quarter of fiscal year 2026, marking a 5% increase year-over-year. This milestone underscores the company’s robust financial performance and its ability to generate substantial revenue growth despite market challenges.

Strengthened Balance Sheet

In a strategic move to fortify its financial standing, Tilray reduced its outstanding debt by $7.7 million, maintaining a net debt-to-EBITDA ratio of 0.07x. The company also reported cash and cash equivalents totaling $265 million, reflecting a solid liquidity position.

Growth in Cannabis Segment

The Cannabis segment saw a 5% increase in revenue year-over-year, reaching $65 million. Notably, the Canadian Adult-Use and International Cannabis businesses contributed significantly with 12% and 10% growth, respectively, highlighting Tilray’s successful expansion in these markets.

Expansion in International Markets

Tilray’s international cannabis revenue grew by 10% to $13.4 million, driven by strategic plans to expand its medical cannabis distribution footprint in Germany. This expansion is a testament to the company’s commitment to broadening its global presence.

Beverage Business Turnaround

Project 420 led to $25 million in annual savings, with brands like Shock Top experiencing a 49% increase in dollar sales in the Southeast. This turnaround indicates a positive trajectory for Tilray’s Beverage business, despite some ongoing challenges.

Challenges in Beverage Segment

Despite efforts to optimize the craft beer SKU portfolio, Beverage segment revenue remained flat due to SKU rationalization and lower gross margins. The gross margin decreased to 38% from 41% last year, reflecting ongoing challenges in this segment.

Permitting Issues in Portugal

Delays in obtaining permits in Portugal have hindered Tilray’s ability to ship cannabis to other countries, impacting its international growth strategy. This issue remains a significant hurdle for the company’s expansion plans.

Lower Gross Margins

Overall, Tilray’s gross margin declined to 27% from 30%, primarily due to lower margins in the Cannabis and Beverage segments. This decline highlights the need for strategic adjustments to improve profitability.

Forward-Looking Guidance

Tilray reaffirmed its fiscal 2026 guidance, projecting adjusted EBITDA between $62 million and $72 million. The company anticipates continued growth in its Canadian Adult-Use and International Cannabis businesses, while also focusing on optimizing its Beverage segment and expanding its Wellness and Distribution segments.

In summary, Tilray’s earnings call reflected a balanced sentiment, with notable achievements in revenue growth and international expansion. However, challenges in the Beverage segment and permitting delays in Portugal pose ongoing hurdles. The company’s strategic initiatives and forward-looking guidance indicate a commitment to overcoming these challenges and driving future growth.